XBB: the chosen one from SARS-CoV-2 homologous recombination

References

[1] Turakhia Y , Thornlow B , Hinrichs A , et al. Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape. Nature 2022; 609: 994- 7.

[2] Tamura T , Ito J , Uriu K , et al; Genotype to Phenotype Japan (G2P-Japan) Consortium . Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nat Commun 2023; 14: 2800.

[3] Imai M , Ito M , Kiso M , et al. Efficacy of antiviral agents against omicron subvariants BQ11 and XBB. N Engl J Med 2023; 388: 89- 91.

[4] Zhang X , Chen L-L , Ip JD , et al. Omicron sublineage recombinant XBB evades neutralising antibodies in recipients of BNT162b2 or CoronaVac vaccines. Lancet Microbe 2023; 4: e131.

[5] Yang J , Hong W , Lei H , et al. Low levels of neutralizing antibodies against XBB Omicron subvariants after BA5 infection. Signal Transduct Target Ther 2023; 8: 252.

RIGHTS & PERMISSIONS

2024 The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.